After utilizing single-cell transcriptomic sequencing data to compare differentially expressed genes of HCC patients with stage I, II, III, and IV, we identified the CTSE, which was significantly upregulated in stage IV patients of HCC (Fig. 1A). The gene discussed is CTSE; the disease is hepatocellular carcinoma.